Insilico Medicine
About Insilico Medicine
Insilico Medicine is a clinical-stage biotechnology company that leverages artificial intelligence and deep learning to accelerate drug discovery and development. The company focuses on therapeutic solutions for cancer, fibrosis, immunity, central nervous system diseases, and age-related conditions, utilizing its proprietary Pharma.AI platform to discover novel targets, design new molecules, and advance candidates into human clinical trials.
Company Details
- Website
- https://insilico.com
- Funding
- IPO
- Total Raised
- $549.3M
- Stock Ticker
- 3696.HK
- https://www.linkedin.com/company/in-silico-medicine
- GitHub
- https://github.com/insilicomedicine
Specializations
- AI/ML
- Drug Discovery
- Biotechnology
- Pharmaceutical
- Generative AI
Products & Solutions (11)
| Product | Category | Sub-Category | Description |
|---|---|---|---|
| Chemistry42 | research-development | Drug Discovery AI | A generative AI platform for small molecule drug discovery, streamlining hit identification to lead optimization. |
| DORA | research-development | Drug Discovery AI | AI-driven tool to streamline academic paper drafting and accelerate drug discovery research. |
| Generative Biologics | research-development | Drug Discovery AI | AI-powered platform for generative design and optimization of biologics. |
| inClinico | research-development | Drug Discovery AI | Generative AI-powered platform for data-driven, multimodal prediction of clinical trial outcomes. |
| Life Star1 | research-development | Lab Management & ELN | Accelerating drug discovery with robotic automation and generative AI. |
| Nach01 Foundation Model | research-development | Drug Discovery AI | AI foundation model for AI-native drug discovery, integrated with Microsoft Discovery and available via AWS Marketplace. |
| PandaOmics | research-development | Drug Discovery AI | AI-powered platform for therapeutic target and biomarker discovery and prioritization. |
| Pharma.AI | research-development | Drug Discovery AI | AI-powered drug discovery from target identification to clinical trials |
| PreciousGPT | research-development | Drug Discovery AI | AI models for digital -omics experiments and drug discovery. |
| TargetBench | research-development | Drug Discovery AI | An AI-empowered benchmarking system for novel drug target identification models. |
| TargetPro | research-development | Drug Discovery AI | AI-empowered platform for rapid and precise novel drug target identification. |
Notable Customers
- Sanofi
- Fosun Pharma
- Exelixis
- Menarini Group
- Qilu Pharmaceutical Group
- Syngenta
- Hisun Pharma
- Taigen